Edwards Lifesciences Balance Sheet Health
Financial Health criteria checks 6/6
Edwards Lifesciences has a total shareholder equity of $7.5B and total debt of $597.3M, which brings its debt-to-equity ratio to 8%. Its total assets and total liabilities are $10.1B and $2.6B respectively. Edwards Lifesciences's EBIT is $1.9B making its interest coverage ratio -31.5. It has cash and short-term investments of $2.0B.
Key information
8.0%
Debt to equity ratio
US$597.30m
Debt
| Interest coverage ratio | -31.5x |
| Cash | US$1.99b |
| Equity | US$7.50b |
| Total liabilities | US$2.59b |
| Total assets | US$10.10b |
Recent financial health updates
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24
Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jul 16Recent updates
Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
Aug 30Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Aug 17Edwards Lifesciences Q2: Buy The Dip Amid Guidance Cut
Jul 26Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Jul 26Why Investors Shouldn't Be Surprised By Edwards Lifesciences Corporation's (NYSE:EW) P/E
Jul 12Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jun 24Edwards Lifesciences Corp Looks Bullish (Technical Analysis)
Jun 22Capital Investments At Edwards Lifesciences (NYSE:EW) Point To A Promising Future
May 13Edwards Lifesciences: EPS Acceleration, Shares Poised To Rally (Rating Upgrade)
May 09When Should You Buy Edwards Lifesciences Corporation (NYSE:EW)?
Apr 29Calculating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Apr 15Edwards Lifesciences Corporation's (NYSE:EW) Popularity With Investors Is Clear
Apr 01Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture
Feb 21Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)
Feb 14Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47
Feb 08Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly
Jan 28The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing
Jan 14Edwards Lifesciences: Undervalued With A Substantial Upside Potential
Jan 09Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up
Dec 31Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)
Dec 17Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets
Oct 26Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Oct 23Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?
Oct 09Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Sep 26A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)
Sep 11Edwards Lifesciences: Rising Dominance In Structural Heart Disease
Aug 21Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?
Jul 16Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?
Jun 30Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value
Jun 15Edwards Lifesciences: Valuation Premium Earned, But Shares Are Not Cheap, Technicals Mixed
Jun 12Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?
May 31Financial Position Analysis
Short Term Liabilities: EW's short term assets ($4.5B) exceed its short term liabilities ($1.2B).
Long Term Liabilities: EW's short term assets ($4.5B) exceed its long term liabilities ($1.4B).
Debt to Equity History and Analysis
Debt Level: EW has more cash than its total debt.
Reducing Debt: EW's debt to equity ratio has reduced from 17% to 8% over the past 5 years.
Debt Coverage: EW's debt is well covered by operating cash flow (145%).
Interest Coverage: EW earns more interest than it pays, so coverage of interest payments is not a concern.